Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injection Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Epinephrine ...
The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those ...
CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...
"Epipen" used for emergency use when an acute allergic reaction has occurred has been rising from 100 dollars (about 15,000 yen) to 649.99 dollars (about 74,400 yen) in the last 6 years. In response ...
According to Arizton’s latest research report, the epinephrine auto-injector market is growing at a CAGR of 8.82% during 2023-2029. Stay ahead of the curve with Arizton's exclusive subscription plan, ...
* Mylan says authorized generic, which will reach pharmacies starting next week, has same drug formulation and device functionality as Epipen auto-injector Sign up here. * Authorized generic for ...
EWING, N.J., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that the U.S. Food and Drug Administration (FDA ...
Lineage Therapeutics Inc. has launched generic epinephrine injection, a USP auto-injector, for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback